Literature DB >> 31902617

Two-Stage Exchange Arthroplasty for Periprosthetic Joint Infection Following Total Hip or Knee Arthroplasty Is Associated With High Attrition Rate and Mortality.

Cameron B Barton1, David L Wang1, Qiang An1, Timothy S Brown1, John J Callaghan1, Jesse E Otero1.   

Abstract

BACKGROUND: We sought to determine the ultimate fate of patients undergoing resection arthroplasty as a first stage in the process of 2-stage exchange and evaluate risk factors for modes of failure.
METHODS: A retrospective case study was performed including all patients with minimum 2-year follow-up who underwent first-stage resection of a hip or knee periprosthetic joint infection from 2008 to 2015. Patient demographics, laboratory, and health status variables were collected. The primary outcome analyzed was defined as failure to achieve an infection-free 2-stage revision. Univariate pairwise comparison followed by multivariate regression analysis was used to determine risk factors for failure outcomes.
RESULTS: Eighty-nine patients underwent resection arthroplasty in a planned 2-stage exchange protocol (27 hips, 62 knees). Mean age was 64 years (range, 43-84), 56.2% were males, and mean follow-up was 56.3 months. Also, 68.5% (61/89) of patients underwent second-stage revision. Of the 61 patients who complete a 2-stage protocol, 14.8% (9/61) of patients failed with diagnosis of repeat or recurrent infection. Mortality rate was 23.6%. Multivariate analysis identified risk factors for failure to achieve an infection-free 2-stage revision as polymicrobial infection (P < .004; adjusted odds ratio [AOR], 7.8; 95% confidence interval [CI], 2.1-29.0), McPherson extremity grade 3 (P < .024; AOR, 4.1; 95% CI, 1.2-14.3), and history of prior resection (P < .013; AOR, 4.7; 95% CI, 1.4-16.4).
CONCLUSION: Patients undergoing resection arthroplasty for periprosthetic joint infection are at high risk of death (24%) and failure to complete the 2-stage protocol (32%). Those who complete the 2-stage protocol have a 15% rate of reinfection at 4.5-year follow-up.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  2-stage revision; outcomes; periprosthetic joint infection; resection; total hip arthroplasty; total knee arthroplasty

Year:  2019        PMID: 31902617     DOI: 10.1016/j.arth.2019.12.005

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  6 in total

1.  Repeat two-stage exchange arthroplasty for recurrent periprosthetic hip or knee infection: what are the chances for success?

Authors:  A C Steinicke; J Schwarze; G Gosheger; B Moellenbeck; T Ackmann; C Theil
Journal:  Arch Orthop Trauma Surg       Date:  2022-01-04       Impact factor: 3.067

2.  Periprosthetic Knee Infection - Part 2: Treatment.

Authors:  João Maurício Barretto; André Luiz Siqueira Campos; Nelson Hiroyuki Miyabe Ooka
Journal:  Rev Bras Ortop (Sao Paulo)       Date:  2022-05-27

3.  Successful Two-Stage Exchange Arthroplasty for Periprosthetic Infection Following Total Knee Arthroplasty: The Impact of Timing on Eradication of Infection.

Authors:  Ines Vielgut; Gerold Schwantzer; Andreas Leithner; Patrick Sadoghi; Uldis Berzins; Mathias Glehr
Journal:  Int J Med Sci       Date:  2021-01-01       Impact factor: 3.738

4.  Local antibiotic treatment with calcium sulfate as carrier material improves the outcome of debridement, antibiotics, and implant retention procedures for periprosthetic joint infections after hip arthroplasty - a retrospective study.

Authors:  Katharina Reinisch; Michel Schläppi; Christoph Meier; Peter Wahl
Journal:  J Bone Jt Infect       Date:  2022-01-20

5.  Long Term Results of Two-Stage Revision for Chronic Periprosthetic Hip Infection: A Multicenter Study.

Authors:  Beau J Kildow; Bryan D Springer; Timothy S Brown; Elizabeth Lyden; Thomas K Fehring; Kevin L Garvin
Journal:  J Clin Med       Date:  2022-03-16       Impact factor: 4.241

Review 6.  Systematic review of risk prediction studies in bone and joint infection: are modifiable prognostic factors useful in predicting recurrence?

Authors:  Maria Dudareva; Andrew Hotchen; Martin A McNally; Jamie Hartmann-Boyce; Matthew Scarborough; Gary Collins
Journal:  J Bone Jt Infect       Date:  2021-07-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.